Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

C4 Therapeutics (CCCC) Amortizatization of Intangibles (2019 - 2025)

C4 Therapeutics (CCCC) has 7 years of Amortizatization of Intangibles data on record, last reported at $4.6 million in Q4 2025.

  • For Q4 2025, Amortizatization of Intangibles rose 651.65% year-over-year to $4.6 million; the TTM value through Dec 2025 reached $6.4 million, up 19.24%, while the annual FY2025 figure was $6.4 million, 19.24% up from the prior year.
  • Amortizatization of Intangibles reached $4.6 million in Q4 2025 per CCCC's latest filing, up from -$1.4 million in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $4.6 million in Q4 2025 and bottomed at -$2.3 million in Q2 2022.
  • Average Amortizatization of Intangibles over 5 years is $1.0 million, with a median of $1.0 million recorded in 2021.
  • Peak YoY movement for Amortizatization of Intangibles: plummeted 5765.0% in 2022, then surged 6941.67% in 2023.
  • A 5-year view of Amortizatization of Intangibles shows it stood at $875000.0 in 2021, then skyrocketed by 109.26% to $1.8 million in 2022, then skyrocketed by 82.52% to $3.3 million in 2023, then plummeted by 81.87% to $606000.0 in 2024, then surged by 651.65% to $4.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Amortizatization of Intangibles were $4.6 million in Q4 2025, -$1.4 million in Q3 2025, and $1.7 million in Q2 2025.